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Abstract  
Aim :  Colorec ta l  cancers  are la rgely considered  as  curab le yet  the high  morta l i ty ra tes  associa ted  wi th i t  points  out  a t  
def ic iency in ear ly management of  the disease.  The a im of  th is s tudy was to analyze the diagnost ic  poten t ia l  of  rou tine 
pr imary invest iga t ions  wi th an  at tempt to categorize symptoms for  ear ly referra l  o f  colorec ta l  cancers  pa t ients .   
Methods :  This  s tudy involved  ret rospect ive analysis  of  a  cohort  of  85 pa tien ts  d iagnosed  wi th  colorec ta l  cancer  that  
underwent  surgery in  a  per iod of  one year.  Th e pat ients  were arranged  in to d i fferen t  age -groups to analyze the re la t ive  
incidence and  prognosis  of  the d isease wi th  respect  to genera l i zed  symptoms and  c l in icopathologica l  deta i ls .  
Mult inomial  Logis t ic  Regress ion  analysis  was  employed  to pred ic t  the most  effec t ive set  of  parameter  combinat ions for  
p r imary prognosis  of  the d iseased  s t ate.   
Resul t s :  Abdominal  pa in ,  rec ta l  b leed ing and  change in bowel habi t s were predominant ly reported  symptoms;  however,  
these were imprecise wi th  age ,  sex or  s tage of  cancer.  In t eres t ingly,  a lmost  85% of  the pa t ien ts  were reported  anemic ,  
wi th  a  majori ty of  them (41 .7%) having Hb  < 10 .  Anaemic  pa tien ts  showed s ign i f ican t ly h igher  frequency of  symptoms 
viz.  change in  bowel habit s  (p < 0.023 ) ,  rec ta l  b leed ing (p  <  0 .035)  and/or  abdominal  pa in  ( p < 0 .039 )  compared  to 
non-anaemic  ones .  The co -occurrence of  any two of  the symptoms fur ther  increased  the l ikelihood  of  the d isease in 
anaemic pat ients .   
Conclusion :  A substant ia l  decrease in  hemoglobin  count  wi th  concomitan t  change in bowel habi t s,  rec ta l  b leed ing,  
and/or  abdominal  pa in  could  be considered  as  poten ti a l  referra l  markers  for  ear ly management  of  suspected  colorec tal  
cancers  pa t ients .  
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Introduction  
Colorectal cancer is the third most common 
cancers claiming over 6 million lives every year 
[1,2] with over 2.5 million deaths annually in asian 
subcontinent alone [2]. Despite being much 
curable and preventable [1, 3], the higher mortality 
rates points towards deficiencies in early prognosis 
and management of the disease. Although, there 
have been remarkable advances in medical 
diagnostics from past few decades, yet commonly 
practiced medical procedures are largely unable to 
diagnose early stage colorectal cancers putting 
large number of patients at risk of developing 
advanced stage cancers. There is an immediate 
need to address the deficiencies in clinical 
diagnostics at primary level to overcome or restrict 
cancer related deaths. In this study, we analyzed 
generalized symptoms associated with colorectal 
cancers and the efficacy of routine clinical 
investigations with an aim to stress upon the need 
for detailed examination of patients with clinically 
relevant symptoms of colorectal cancer. 
Methods  
Study Design: The study was carried out on a 
cohort of 85 patients referred for surgical resection 
of the tumor growth of the colon. The patients 
were examined by routine procedures viz. Digital 
rectal examination (DRE), Proctosigmoidoscopy, 
Colonoscopy and Contrast Enhanced Computed 
Tomography (CECT) besides general check-up 
before being operated upon. Serological analyses 
include blood CEA levels, WBC count, 
hemoglobin estimation etc. Biopsies of the colonic 
lesions were sent to pathological laboratory for 
detailed examination. 
Patient grouping: For analyzing the relative 
incidence and clinicopathological details, patients 
were grouped in five age-groups: Group 1 (< 30 
years); Group 2 (31-45 years); Group 3 (46-60 
years); Group 4 (61-70 years) and Group 5 (> 70 
years). For MLR analysis, patients were grouped 
according to state of haemoglobin 
(anaemic/non-anemic).  
Data analysis: Clinocopathological data were 
collected from all the patients as per institutional 
ethical guidelines. The data were stratified by 
patient symptoms, primary investigations and 
clinical findings, and compared across all the 
age-groups. Surgical observations were also 
collected at the time of surgery for comparison. 
The outcome of the clinicopathological variables 
were summarized as percentage of patients bearing 
the symptom/state within the specified group. 
Multinomial logistic regression (IBM
®
 SPSS
® 
v.22) was used to compare chief 
complaints/symptoms associated with anaemic 
patients compared to non-anaemic subjects. 
Differences were considered statistically 
significant at p < 0.05.  
Results 
Incidence rates and generalized symptoms:  Based 
upon the clinicopathological data, the incidence 
rates were calculated using age, sex, demography 
or smoking history [Table 1]. Most of the patients 
were aged between 46-60 years (34.12%), 
followed by 61-70 (21.18%), 31-45 (20%), 16-30 
(16.47%) and > 70 (8.24%). Except patients below 
30 years of age, the Male: Female ratio was higher 
(> 1) across all the age groups. The primary 
investigation reports compared across all the 
age-groups revealed majority of patients with 
symptoms viz. abdominal pain, rectal bleeding or 
change in bowel habits across all the groups [Table 
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2].  
Clinical investigations vs Surgical findings: 
Histologically, almost all the patients (94.44%) 
were diagnosed for adenocarcinoma [Table S1]. 
More than 48% of the patients were diagnosed 
with advanced grade tumors [Moderately 
differentiated + poorly differentiated CRC], 
however, symptoms viz. abdominal pain, rectal 
bleeding, change in bowel habits were equally 
prevalent irrespective of tumor grade [Table S2]. 
Four critical parameters were analyzed in clinical 
and surgical reports to ascertain the efficacy of 
clinical diagnosis related to tissue damage or stage 
of cancer: 1) Breaching of abdominal serosa by 
cancerous cells; 2) Lymph node involvement; 3) 
Accumulation of intestinal fluids; and 4) Liver 
metastasis. Surgical observations revealed much 
advanced cancers which were reported less 
invasive type by clinical examinations [Table S3], 
which could be a consequence of delay in the 
surgical procedure. 
Carcinoembryonic antigen (CEA) levels: 
Serological levels of CEA were analyzed across 
the age-groups or cancer types; however, these 
were entirely indecisive to correlate with onset, 
progress or grade of cancer [Table S4].  Values 
below 2.5 ng / ml were considered as normal. 
Hemoglobin count: Analysis of the clinical 
reports of patients showed that about ~85 percent 
of the patients were anemic [Hb: < 12.1g/dl 
(Females) < 13.8g/dl (Males)]. The anemic 
patients outnumbered non-anemic ones across all 
age-groups. A scale based analysis of hemoglobin 
count showed that almost 42% of the patients 
(19.05% males; 22.62% females) had Hb values 
less than 10g/dl, 23.81% (11.90% males; 11.90% 
females) had Hb values between 10-11 g/dl and 
14.29% (3.57% males; 10.71% females) had Hb 
values of 11-12g/dl [Table 3]. Anemic condition 
followed a regular trend with the type/grade of 
cancer, being more prominent in early grade 
compared to advanced grade cancers [Table 4]. 
 
Table 1 Details of patients registered in the study 
* Data expressed as Average age ± SD 
 
 
Age Group 16-30 31-45 46-60 61-70 >70 
 % n % n % n % n % n 
No. of Patients 16.47 14 20 17 34.12 29 21.18 18 8.24 7 
Average Age (Yrs)* 26.06 ± 5.54 40.23±4.14 54.82±4.57 66.16±3.13 76.42±3.69 
Gender           
Females 71.43 10 41.18 7 34.48 10 44.44 8 42.86 3 
Males 28.57 4 58.82 10 65.52 19 55.56 10 57.14 4 
Residence           
Urban 21.43 3 23.53 4 44.83 13 50.00 9 57.14 4 
Rural 78.57 11 76.47 13 55.17 16 50.00 9 42.86 3 
Smoking history           
Smokers 14.29 2 47.06 8 41.38 12 38.89 7 71.43 5 
Ex/Non-Smokers 85.71 12 52.94 9 58.62 17 61.11 11 28.57 2 
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Table 2 Primary investigations reports of the patients with Colorectal cancers.  
 
Age Group 16-30 31-45 46-60 61-70 >70 
General Symptoms + - + - + - + - + - 
Abdominal Pain 71.43 28.57 58.82 41.18 68.97 31.03 44.44 55.56 42.86 57.14 
Intestinal Swelling 14.29 85.71 29.41 70.59 6.90 93.10 11.11 88.89 28.57 71.43 
Anaemia 85.71 14.29 94.12 5.88 89.29 10.71 77.78 22.22 100 - 
Bleeding PR 57.14 42.86 52.94 47.06 68.97 31.03 77.78 22.22 71.43 28.57 
Change in Bowel Habits 78.57 21.43 70.59 29.41 68.97 31.03 77.78 22.22 100 - 
Distension 7.14 92.86 17.65 82.35 6.90 93.10 11.11 88.89 14.29 85.71 
Generalized Weakness 50.00 50.00 23.53 76.47 27.59 72.41 55.56 44.44 - 100 
Pallor 57.14 42.86 47.06 52.94 58.62 41.38 44.44 55.56 28.57 71.43 
Tenderness 7.14 92.86 11.76 88.24 3.45 96.55 11.11 88.89 14.29 85.71 
Clinical findings + - + - + - + - + - 
Co-morbidity 7.14 92.86 29.41 70.59 53.57 46.43 55.56 44.44 85.71 14.29 
Past History of any 
Cancer/ pre-cancerous 
growth 
- 100 - 100 3.45 96.55 - 100 - 100 
Synchronous Lesions 22.22 77.78 - - 3.45 68.97 21.43 78.57 - 100 
Serosa Breached 50.00 50.00 41.18 58.82 34.48 65.52 44.44 55.56 57.14 42.86 
Lymphadenopathy 50.00 50.00 70.59 29.41 51.72 48.28 55.56 44.44 57.14 42.86 
Ascites - 100 5.88 94.12 6.90 93.10 - 100 14.29 85.71 
Data obtained from patient registry and includes reports based upon DRE, Proctosigmoidoscopy, Colonoscopy and 
CECT. Values are expressed as relative percentage with the specified group (s); (+) sign indicates presence of the 
specified variable, (-) sign indicates its absence. 
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Table 3 Hemoglobin variations in unit scale 
 
  <10g/dl 10-11g/dl 11-12g/dl 12-13g/dl 13-14g/dl >14g/dl 
Males 19.0 11.9 3.6 7.1 4.8 1.2 
Females 22.6 11.9 10.7 4.8 1.2 1.2 
Overall %age 41.7 23.8 14.3 11.9 6.0 2.4 
Data expressed as relative percentage of patients. 
 
Table 4 Hemoglobin variations with grade of cancer 
 
Status of Hemoglobin 
Tumor Grade 
WD MD PD 
Normal 11.8 3.5 0.0 
Anaemic 40.0 29.4 15.3 
Total 51.8 32.9 15.3 
Data expressed as relative percentage of patients. WD: well differentiated; MD: Moderately differentiated; PD 
poorly differentiated.  
 
Multivariate analysis: Using Multinomial 
logistic regression (IBM
®
 SPSS
® 
v.22) analyses, 
change in bowel habits, rectal bleeding, or 
abdominal pain were rendered as potential 
symptoms associated with anaemia in colorectal 
cancer patients compared to non-anaemic patients. 
Change in bowel habits showed significant 
coherence with anemic state (OR = 2.139, p = 
0.023), followed by abdominal pain (OR = 1.664, p 
= 0.035) and rectal bleeding (OR = 1.299, p = 
0.039) [Table 5]. A concurrent presence of any two 
of these symptoms viz change in bowel habits, 
rectal bleeding, or abdominal pain further 
enhanced the likelihood of the disease in anaemic 
patients compared to non-anaemic patients. 
 
Table 5 MLR estimates of chief complaints associated with anaemia in colorectal cancer patients 
 
Hemoglobin statea 
Odds ratio 
Exp(B) 
95% Confidence Interval for 
Exp(B) 
P value 
Lower Bound Upper Bound 
Anaemic      
 Change in Bowel Habits 2.139 0.051 0.186 0.023 
Bleeding PR 1.664 0.041 0.170 0.035 
Abdominal Pain 1.299 0.025 0.167 0.039 
Change in Bowel Habits + Bleeding PR 2.603 0.042 0.115 0.021 
Change in Bowel Habits + Abdominal 
Pain 
2.421 0.043 0.185 0.026 
Bleeding PR + Abdominal Pain 1.310 0.052 0.171 0.029 
a. The reference category is: Non-anaemic. 
 Mokhdomi TA et al. American Journal of Clinical Cancer Research   2014, 2:14-20 
  
Ivy Union Publishing | http: //www.ivyunion.org April *, 2014 | Volume 2 | Issue 1  
Page 6 of 7 
Discussion 
Colorectal cancers tend to continue as the third 
most commonly found cancers [9], with mortality 
rates of ~ 8% [9, 10] owing to late detection or 
poor prognosis of the patients [11, 12]. Colorectal 
cancers develop gradually with the formation of 
non-cancerous “polyp”. The transformation of 
“polyps” into adenomas may go undetected till 
advanced stage cancers resulting in severe 
mortality. The adenomas growing at the intestinal 
lining may alter intestinal secretions or invade 
blood vessels giving typical symptoms of the colon 
cancer viz bowel disturbances, rectal bleeding, 
abdominal pain etc. However, the onset of these 
symptoms may not always be correlated with stage 
or severity of cancer as is evident from the 
disagreements between clinical and surgical 
findings highlighted in this report, which could 
only be attributed to the delay in advanced referral 
of the patients [13]. Clinicians are now engaged to 
ascertain the diagnostic value of symptoms 
associated with colorectal cancer in primary care 
[4, 14] alone to allow better referral investigations 
for these patients [15]. The symptoms associated 
with colorectal cancer have been described in 
numerous clinical studies [5-7], together with their 
estimated risks. A study by Hamilton et al (2005) 
reported a strong association between incidence of 
colorectal cancers and severity of anaemia [8], 
while other studies held the argument insensitive 
[16]. Our study records a strong prevalence of 
colon cancers associated with low hemoglobin 
levels coupled with the characteristic symptoms 
viz rectal bleeding change in bowel habits and 
abdominal pain, supporting the importance of 
primary investigations in colon cancers. 
Furthermore, this study recommends a prompt 
referral of patients to advanced care once the 
patients are admitted with complaints of anaemia, 
rectal bleeding, and change in bowel habits and/or 
abdominal pain. Additionally, this type of a pilot 
study highlighted non-age relatedness of anaemia 
with risk of developing colorectal cancers and 
could possibly encourage further research in 
clinical association of hemoglobin deficiency and 
cancers; besides it could also help to review 
current referral of patients in primary care. 
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